Max Perilstein

Fox Chase Cancer Center

Papers

1

Total Citations

2

H-Index

1

About

Dr. Max Perilstein is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for benign prostatic hyperplasia (BPH). His major contributions lie in refining robot-assisted transvesical simple prostatectomy, particularly through the development of a circumferential mucosal anastomosis that preserves both urinary and sexual function. In a landmark study of 292 patients, Dr. Perilstein demonstrated exceptional long-term outcomes, with significant improvements in American Urologic Association Symptoms Scores (AUASS) and robust preservation of erectile function, setting a new standard for large-gland BPH surgery. This work, published in 2025, has already garnered 2 citations, reflecting its immediate impact on clinical practice. Dr. Perilstein’s research is notable for its rigorous focus on patient-reported outcomes, bridging the gap between technical innovation and quality of life. His achievements include pioneering the use of the Xi robotic system for this complex procedure, offering a reproducible, safe alternative to open surgery. For students and researchers, Dr. Perilstein exemplifies how surgical innovation can transform patient care, making him a leading voice in robotic urology.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted transvesical simple prostatectomy with circumferential mucosal anastomosis: long-term urinary and sexual function outcomes in a 292 patient cohort
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Fox Chase Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago